CAS 162831-31-4

1,5-Pentanediamine,N1-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-, hydrobromide (1:2)

Description:

1,5-Pentanediamine, N1-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-, hydrobromide (1:2) is a chemical compound characterized by its unique structure, which includes a pentanediamine backbone and a tricyclic decyl group. This compound features two functional amine groups, which can participate in hydrogen bonding and contribute to its solubility in polar solvents. The hydrobromide salt form indicates that it is a protonated version of the base amine, enhancing its stability and solubility in aqueous environments. The presence of the tricyclic structure may impart specific steric and electronic properties, influencing its reactivity and potential applications in organic synthesis or medicinal chemistry. As a hydrobromide, it is likely to exhibit characteristics typical of ammonium salts, such as increased ionic strength and potential use in various chemical reactions. Overall, this compound's unique structural features and salt form suggest it may have specialized applications in research or industry, particularly in fields requiring specific amine functionalities.

Formula: C₁₆H₃₀N₂BrH

Synonyms:

• 1,5-Pentanediamine,N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-, dihydrobromide (9CI)
• Iem 1754

IEM-1754

CAS: 162831-31-4

Formula: C₁₆H₃₂Br₂N₂

Purity: 98%

Molecular weight: 412.2467

Ref: IN-DA00AKRT

IEM 1754 2HBr

CAS: 162831-31-4

IEM 1754 2HBr

Purity: ≥98%

Molecular weight: 412.25g/mol

Ref: 54-BUP15763

IEM 1754 2HBr

CAS: 162831-31-4

IEM 1754 2HBr is a glutamate antagonist that blocks the activity of glutamate receptors in the central nervous system. It has been shown to have a low potency and to be rapidly metabolized with an elimination half-life of about 10 minutes. IEM 1754 2HBr has pharmacokinetic properties that make it suitable for oral administration, which can be taken as a tablet or capsule. The drug is used in experimental models to study glutamate receptor activity and locomotor activity. IEM 1754 2HBr has been shown to have no effects on animals when administered at doses up to three times the maximum therapeutic dose. Side effects are limited to mild drug reactions, such as constipation, nausea, vomiting, and headache. IEM 1754 2HBr also may reduce autoimmune diseases by blocking the release of proinflammatory cytokines and chemokines from activated T cells.

Formula: C₁₆H₃₀N₂·2HBr

Purity: Min. 95%

Molecular weight: 412.25 g/mol

Ref: 3D-MGA83131

IEM 1754 2HBr

CAS: 162831-31-4

IEM 1754 2HBr (IEM 1754 dihydrobromide) is a selective AMPA/kainate receptor blockers for GluR1 and GluR3 with IC50 of 6 μM.

Formula: C₁₆H₃₀N₂·2HBr

Purity: 99.04% - 99.72%

Color and Shape: Solid

Molecular weight: 412.25

Ref: TM-T6134